LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the ...

Grafts (+24%), patches (+13%) and carotid shunts (+18%) drove Q3 sales growth ... respectively. Chairman/CEO George LeMaitre said, “2024 is shaping up to be a year of healthy sales and profit growth.

LeMaitre Vascular Inc (NASDAQ:LMAT) reported a strong 16% sales growth in Q3 2024, driven by significant increases in grafts, patches, and carotid shunts. The company achieved a 49% EPS growth ...